The biopharmaceutical company is screening patients for its randomized, double-blind, placebo-controlled U.S. study.
The drug is a proprietary combination antibiotic therapy in oral pill formulation. Researchers are looking for 240 patients in 50 clinical sites throughout the U.S., Canada and Israel.
More Articles on Gastroenterology:
Dr. Gurpreet Singh Joins Woodland Healthcare in California
7 Ways to Use Key Quality Metrics to Improve Gastroenterology Centers
Drs. Anthony Masciarelli, Renjy Vattasseril Join Cape Regional Medical Center’s ASC
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
